Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PVLA | MTVA | KAPA | ||
| Company | Palvella Therapeutics Inc | Metavia Inc | Kairos Pharma Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE Arca | ||
| Open | 15.00 | 2.30 | 1.5100 | ||
| High | 15.60 | 2.30 | 1.5865 | ||
| Low | 14.00 | 2.11 | 0.8510 | ||
| Last | 14.25 | 2.13 | 1.0300 | ||
| Change | -0.48 | -0.19 | -0.4700 | ||
| % Change | -3.26% | -8.19% | -31.33% | ||
| Volume | 26,905 | 51,097 | 1,052,571 | ||
| 20-Day Average Volume | 44,315 | 334,289 | 108,648 | ||
| Previous Close | 14.73 | 2.32 | 1.5000 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 13.28 | 2.04 | 1.6005 | ||
| 20-Day Raw Stochastic | 49.76% | 50.00% | 16.82% | ||
| 20-Day Relative Strength | 49.36% | 47.37% | 32.44% | ||
| Weighted Alpha | -47.86 | -54.10 | N/A | ||
| Today's Opinion | 24% Sell | 80% Sell | N/A | ||
| Previous Opinion | 8% Sell | 80% Sell | N/A | ||
| Last Month's Opinion | 40% Buy | 100% Sell | N/A | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +18.75% since 12/31/24 | +4.93% since 12/31/24 | -32.24% since 12/31/24 | ||
| Low | 11.28 on 01/02/25 | 2.02 on 01/02/25 | 0.8500 on 01/08/25 | ||
| High | 15.67 on 01/07/25 | 2.75 on 01/06/25 | 1.6500 on 01/07/25 | ||
| 1-Month | |||||
| %Chg | -12.74% since 12/06/24 | -7.79% since 12/06/24 | -29.45% since 12/06/24 | ||
| Low | 11.17 on 12/30/24 | 1.51 on 12/23/24 | 0.8500 on 01/08/25 | ||
| High | 17.36 on 12/10/24 | 2.75 on 01/06/25 | 1.9200 on 12/13/24 | ||
| 3-Month | |||||
| %Chg | -11.17% since 10/08/24 | -19.62% since 10/08/24 | -30.41% since 10/08/24 | ||
| Low | 11.17 on 12/30/24 | 1.51 on 12/23/24 | 0.8500 on 01/08/25 | ||
| High | 17.70 on 11/06/24 | 3.27 on 10/17/24 | 2.7500 on 11/13/24 | ||
| 6-Month | |||||
| %Chg | +89.75% since 07/08/24 | -53.77% since 07/08/24 | N/A since 09/16/24 | ||
| Low | 6.20 on 07/12/24 | 1.51 on 12/23/24 | 0.8500 on 01/08/25 | ||
| High | 18.68 on 08/26/24 | 5.16 on 07/15/24 | 4.0000 on 09/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 19,446 | 19,989 | 19,271 | ||
| Shares Outstanding, K | 1,320 | 8,616 | 12,847 | ||
| Annual Sales | 42,810,000 | 0 | 0 | ||
| Annual Net Income | -24,540,000 | -12,470,000 | -1,812,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -3,590,000 | -5,650,000 | -1,047,000 | ||
| 60-Month Beta | 0.67 | -0.22 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.19 on 11/13/24 | -0.55 on 11/07/24 | -0.10 on 11/14/24 | ||
| Latest Earnings Date | N/A | N/A | 02/13/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||